Cargando…

Posaconazole and isavuconazole induced hypomagnesaemia

Detalles Bibliográficos
Autores principales:	Burston, John, Robertson, Mark, van Hal, Sebastian, Pinto, Angie N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258827/ https://www.ncbi.nlm.nih.gov/pubmed/30510894 http://dx.doi.org/10.1016/j.mmcr.2018.09.007

Ejemplares similares

411. Tolerability of Isavuconazole After Posaconazole Toxicity in Leukemia Patients
por: DiPippo, Adam J, et al.
Publicado: (2018)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
por: Ruan, Lan-hong, et al.
Publicado: (2021)

Hypomagnesaemia induced recurrent cerebellar ataxia: an interesting case with successful management
por: Kumar, Singh Saraj, et al.
Publicado: (2020)

Case Report: Investigation and molecular genetic diagnosis of familial hypomagnesaemia
por: Willows, Jamie, et al.
Publicado: (2019)

Hypomagnesaemia and Magnesium Deficiency
por: Sutton, R. A. L.
Publicado: (1968)

Hypomagnesaemia associated with long-term use of proton pump inhibitors
por: Toh, James Wei Tatt, et al.
Publicado: (2015)

Hydrochlorothiazide: Refractory hypokalaemia and hypomagnesaemia in an elderly patient: case report
Publicado: (2013)

Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016)

Late-onset isavuconazole-induced liver injury
por: Bongomin, Felix, et al.
Publicado: (2018)

Hypomagnesaemia – One Cause To Remember!
por: Viegas, Ana Filipa, et al.
Publicado: (2022)

358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018)

Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations
por: Li, Julius, et al.
Publicado: (2015)

The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
por: Tai, Yong Ting, et al.
Publicado: (2020)

Posaconazole‐induced hypertension in children with cystic fibrosis
por: Marpole, Rachael, et al.
Publicado: (2021)

A novel CLDN16 mutation in a large family with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis
por: Deeb, Asma, et al.
Publicado: (2013)

Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series
por: Soman, Rajeev, et al.
Publicado: (2022)

Upper extremity Histoplasma capsulatum treatment with isavuconazole
por: Le, Janet, et al.
Publicado: (2021)

Hypomagnesaemia induced hypocalcemia mimicking as acute exacerbation of COPD—Rare cause of a common presentation: A case report
por: Roy, Shankar, et al.
Publicado: (2020)

Gynecomastia and hypertension in a patient treated with posaconazole
por: Thompson, George R., et al.
Publicado: (2020)

Exposure of Cryptococcus neoformans to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole
por: Drakulovski, Pascal, et al.
Publicado: (2023)

Severe hypomagnesaemia with tetany following ESHAP protocol
por: Majumdar, Gautam
Publicado: (2002)

Posaconazole: Lack of efficacy: case report
Publicado: (2022)

Posaconazole as rescue therapy in African histoplasmosis
por: Gonçalves, Daniel, et al.
Publicado: (2013)

941. Isavuconazole Prophylaxis Against Invasive Fungal Infection: A Pooled Analysis with a Comparison of Posaconazole Delayed-release Tablet Prophylaxis
por: Lee, Chaeryoung, et al.
Publicado: (2021)

Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

A Patient on Long-Term Proton Pump Inhibitors Develops Sudden Seizures and Encephalopathy: An Unusual Presentation of Hypomagnesaemia
por: Gandhi, Nirav Y., et al.
Publicado: (2012)

Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia
por: Miller, Ann, et al.
Publicado: (2018)

Isavuconazole/piperacillin/tazobactam/voriconazole: Drug-induced liver injury: case report
Publicado: (2022)

Posaconazole: Various toxicities: 2 case reports
Publicado: (2022)

P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis
por: Soman, Rajeev, et al.
Publicado: (2022)

Antibacterials/isavuconazole/voriconazole: Lack of efficacy: case report
Publicado: (2020)

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics
por: Claverie-Martin, Felix
Publicado: (2015)

Marked peripheral eosinophilia due to prolonged administration of posaconazole
por: Alharbi, Maher, et al.
Publicado: (2017)

Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018)

Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
por: Huggins, Jonathan, et al.
Publicado: (2018)

Amphotericin-b-liposomal/isavuconazole: Lack of efficacy: case report
Publicado: (2021)

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report
por: Verfaillie, Saartje, et al.
Publicado: (2022)

Hypomagnesaemia As a Mortality Risk Factor in Protein-energy Malnutrition
por: Karakelleoglu, Cahit, et al.
Publicado: (2011)

Posaconazole-Induced Hypertension Masquerading as Congenital Adrenal Hyperplasia in a Child with Cystic Fibrosis
por: Agarwal, Neha, et al.
Publicado: (2020)

Severe Posaconazole-Induced Glucocorticoid Deficiency with Concurrent Pseudohyperaldosteronism: An Unfortunate Two-for-One Special
por: Villar-Prados, Alejandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mo9jhe75c1p0bhjan2tp7td725